Search

everythinglearnresearchcommunity

for

Search:↓

Agaricus subrufescens improves ovarian function and biochemical health in rats with PCOS.

Polycystic Ovary Syndrome (PCOS) in teenagers is a complex condition linked to genetics and environment, often associated with obesity and insulin resistance, and is treated with lifestyle changes and medication.

Hormonal changes and conditions like polycystic ovarian syndrome are major causes of adult acne in women, with varying prevalence among different ethnicities.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Researchers found an RNA transcript that might help control a growth factor linked to tumor development.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Women with PCOS who have high male hormone levels often also have insulin resistance.

Polish medical societies recommend personalized treatment for PCOS based on the patient's specific symptoms and use the Rotterdam criteria for diagnosis.

Women with nonclassic 21-hydroxylase deficiency can have successful pregnancies through IVF, with certain factors affecting their chances.

The research provides a gene-based framework for hair biology, highlighting the Hippo pathway's importance and suggesting links between hair disorders, cancer pathways, and the immune system.

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Clofazimine may be effective for treating ashy dermatosis.

The new rodent model successfully mimics non-lean human PCOS symptoms.

Clofazimine successfully treated a man's ashy dermatosis, clearing his skin lesions.

Omega-6 and LDL cholesterol increase the risk of hair loss.

Women with PCOS have a similar chance of getting pregnant using assisted reproductive treatment as those without PCOS.

PCOS is a hormonal disorder causing symptoms like irregular periods and acne, and increases the risk of diabetes and heart disease.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Transvaginal hydrolaparoscopy is effective for increasing ovulation and pregnancy rates in women with PCOS who didn't respond to clomiphene.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Finasteride exposure harms tadpole reproduction and hormone balance.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

The foreword introduces a medical issue discussing male hormonal health, treatments, and the effects of conditions like obesity and aging.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Eating disorders are serious, often undiagnosed conditions requiring early treatment, with anorexia being the most deadly and binge-eating the most treatable.